News & Insights



GSK investing in Rockville site

GSK plans to invest $139 million into its Rockville, Maryland site to expand bulk drug capacity by about 50%. This comes as news that the US demand for Benylsta, its drug to fight lupus is growing and a pending approval of a new formulation later this year.

Click here to view the entire article.




BACK TO NEWS & INSIGHTS